Aimovig, also known as erenumab, is an injection used for the prevention of migraines that occur at least 4 days a month. It is typically considered as an option for patients who have tried multiple oral treatments without adequate relief. This medication is administered as a once-a-month dose. It was approved by Health Canada in August 2018 and there is limited data on its effectiveness and safety in specific populations such as children, pregnant women, and individuals over the age of 65. Reported side effects include pain and redness at the injection site, constipation, itching, and muscle spasms.
Similar Questions
I've heard that the new vaccine is supposed to be more effective. Should we wait for its release to get the booster shot?
General1 answer
I heard about ear drops to unclog them. Do I need a doctor's prescription for this kind of thing?
General1 answer
I have been taking hormones prescribed for 5 years and now I have heard about "bio-identical hormones". Should I switch?
General1 answer
My milk production seems insufficient. What can I do? I have heard about fenugreek and blessed thistle, can they help?
General1 answer
Conception and COVID vaccine. I'm currently trying to conceive, and I heard of two friends who lost their menstruation.
General1 answer
Information provided by Medimap is for general purpose only and is not a substitute for medical advice. Click here to review our Terms of Service.